Literature DB >> 9326768

Molecular basis of ACAID.

J W Streilein1.   

Abstract

Mesh：

Substances：

Year:  1997        PMID： 9326768     DOI： 10.3109/09273949709116898

Source DB:  PubMed          Journal:  Ocul Immunol Inflamm        ISSN： 0927-3948            Impact factor:   3.070


× No keyword cloud information.
  4 in total

1.  Animal models of scarring control.

Authors:  David L Williams
Journal:  Eye (Lond)       Date:  2019-12-10       Impact factor: 3.775

2.  Versican G1 domain enhances adenoviral-mediated transgene expression and can be modulated by inhibitors of the Janus kinase (JAK)/STAT and Src family kinase pathways.

Authors:  Patricia Y Akinfenwa; Wesley S Bond; Cristhian J Ildefonso; Mary Y Hurwitz; Richard L Hurwitz
Journal:  J Biol Chem       Date:  2017-07-06       Impact factor: 5.157

3.  A penetrating ocular injury can affect the induction of anterior chamber-associated immune deviation.

Authors:  Fang Lei; Junfeng Zhang; Jinsong Zhang; Hao He; Ying Du; Peizeng Yang
Journal:  Mol Vis       Date:  2008-02-11       Impact factor: 2.367

4.  Iris pigment epithelium expressing CD86 (B7-2) directly suppresses T cell activation in vitro via binding to cytotoxic T lymphocyte-associated antigen 4.

Authors:  Sunao Sugita; J Wayne Streilein
Journal:  J Exp Med       Date:  2003-06-30       Impact factor: 14.307
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.